Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients

Abstract

Serum adropin level was significantly lower in type 2 diabetic patients than in non-diabetic patients and was inversely and independently associated with angiographic severity of coronary atherosclerosis, suggesting that serum adropin serves as a novel predictor of coronary atherosclerosis.